Artivion, Inc. (AORT) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AORT SEC filings page.
Artivion, Inc. (AORT) reported $471.5M in revenue over the twelve months to Jun 30, 2026, up 16.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue growth returned the company to a profit, but heavier overhead and reinvestment kept cash economics thin.
The latest sales expansion came with operating-margin compression, from10.0% in FY2024 to7.7% in FY2025, showing that additional volume was not converting into operating profit as efficiently. Meanwhile, cash conversion weakened after investment: operating cash flow reached$39.9M , but free cash flow was only$839K because capital spending absorbed nearly all internally generated cash.
Stable gross margins near 64% alongside lower operating margins suggests the pressure was below production costs rather than in the core product economics. The move from a net loss of
Balance-sheet leverage declined: debt fell to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Artivion, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Artivion, Inc. has an operating margin of 7.6%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 43/100, indicating healthy but not exceptional operating efficiency. This is down from 10.0% the prior year.
Artivion, Inc.'s revenue grew 13.6% year-over-year to $441.3M, a solid pace of expansion. This earns a growth score of 69/100.
Artivion, Inc. has elevated debt relative to equity (D/E of 0.48), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 24/100, reflecting increased financial risk.
With a current ratio of 3.53, Artivion, Inc. holds $3.53 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 84/100.
While Artivion, Inc. generated $39.9M in operating cash flow, capex of $39.0M consumed most of it, leaving $839K in free cash flow. This results in a low score of 30/100, reflecting heavy capital investment rather than weak cash generation.
Artivion, Inc.'s ROE of 2.2% shows moderate profitability relative to equity, earning a score of 44/100. This is up from -4.8% the prior year.
Artivion, Inc. scores 2.35, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($1.1B) relative to total liabilities ($436.6M). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Artivion, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Artivion, Inc. generates $4.08 in operating cash flow ($39.9M OCF vs $9.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Artivion, Inc. earns $1.27 in operating income for every $1 of interest expense ($33.7M vs $26.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Artivion, Inc. generated $125.8M in revenue in Q2 2026. This represents an increase of 11.3% from the same quarter a year earlier. Against the prior quarter it is up 8.1%.
Artivion, Inc.'s EBITDA was -$1.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 111.6% from the same quarter a year earlier. Against the prior quarter it is down 113.3%.
Artivion, Inc. reported -$13.5M in net income in Q2 2026. This represents a decrease of 1104.5% from the same quarter a year earlier. Against the prior quarter it is down 1053.4%.
Artivion, Inc. earned -$0.28 per diluted share (EPS) in Q2 2026. This represents a decrease of 1033.3% from the same quarter a year earlier. Against the prior quarter it is down 1033.3%.
Cash & Balance Sheet
Artivion, Inc. recorded an outflow of $12.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 202.5% from the same quarter a year earlier. Against the prior quarter it is down 75.4%.
Artivion, Inc. held $77.3M in cash against $363.4M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Artivion, Inc.'s gross margin was 64.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
Artivion, Inc.'s operating margin was -6.7% in Q2 2026, reflecting core business profitability. This is down 14.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 11.6 percentage points.
Artivion, Inc.'s net profit margin was -10.7% in Q2 2026, showing the share of revenue converted to profit. This is down 11.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 12.0 percentage points.
Artivion, Inc.'s ROE was -3.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 3.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.3 percentage points.
Capital Allocation
Artivion, Inc. invested $9.1M in research and development in Q2 2026. This represents an increase of 28.2% from the same quarter a year earlier. Against the prior quarter it is up 2.4%.
Artivion, Inc. invested $10.7M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 227.0% from the same quarter a year earlier. Against the prior quarter it is up 34.3%.
Not reported for Q2 2026.
AORT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $125.8M+11.3% | $116.3M+17.5% | $116.0M+19.2% | $113.4M+18.4% | $113.0M+15.3% | $99.0M+1.6% | $97.3M+3.9% | $95.8M+9.0% |
| Cost of Revenue | $45.2M+13.5% | $40.9M+15.5% | $42.8M+19.7% | $39.0M+12.1% | $39.9M+14.9% | $35.4M+2.7% | $35.8M+9.9% | $34.8M+10.1% |
| Gross Profit | $80.5M+10.1% | $75.4M+18.7% | $73.1M+18.9% | $74.4M+21.9% | $73.1M+15.5% | $63.6M+1.0% | $61.5M+0.7% | $61.0M+8.4% |
| R&D Expenses | $9.1M+28.2% | $8.8M+31.4% | $9.1M+23.2% | $8.1M+22.3% | $7.1M-5.8% | $6.7M-3.1% | $7.4M-3.2% | $6.6M+2.9% |
| SG&A Expenses | $79.8M+38.4% | $60.8M+11.2% | $56.8M+10.5% | $57.3M+14.5% | $57.7M+16.9% | $54.7M+78.3% | $51.4M+2.3% | $50.0M-2.1% |
| Operating Income | -$8.4M-199.8% | $5.8M+169.8% | $10.7M+300.1% | $12.5M+185.8% | $8.4M+28.8% | $2.1M-91.5% | $2.7M-15.9% | $4.4M+452.7% |
| EBITDA | -$1.6M-111.6% | $12.1M+59.8% | $16.4M+83.4% | $18.3M+73.9% | $13.9M+12.3% | $7.6M-75.7% | $9.0M-0.3% | $10.5M+132.5% |
| Interest Expense | $7.3M-0.2% | $5.4M-30.0% | $5.5M-43.3% | $6.1M-27.2% | $7.3M-12.4% | $7.7M-2.1% | $9.8M+56.2% | $8.4M+27.2% |
| Income Tax | $1.8M-15.3% | -$1.1M+39.8% | $4.1M+3554.6% | $554K-45.8% | $2.1M+798.4% | -$1.8M-134.1% | -$119K-103.5% | $1.0M+167.5% |
| Net Income | -$13.5M-1104.5% | $1.4M+380.6% | $2.4M+114.7% | $6.5M+384.2% | $1.3M+163.4% | -$505K-106.7% | -$16.5M-314.7% | -$2.3M+76.7% |
| EPS (Basic) | -$0.28-1033.3% | $0.03+400.0% | $0.06+115.4% | $0.14+380.0% | $0.03+160.0% | -$0.01-105.6% | -$0.39-290.0% | -$0.05+79.2% |
| EPS (Diluted) | -$0.28-1033.3% | $0.03+400.0% | $0.05+112.8% | $0.13+360.0% | $0.03+160.0% | -$0.01-105.6% | -$0.39-290.0% | -$0.05+79.2% |
| Diluted Shares (Avg) | 49M+7.0% | 50M+17.8% | N/A | 49M+16.6% | 45M+8.9% | 42M-11.8% | N/A | 42M+2.4% |
AORT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B+27.9% | $883.2M+11.6% | $884.8M+12.1% | $857.7M+6.8% | $838.4M+6.2% | $791.2M+0.9% | $789.1M-0.4% | $803.1M+3.7% |
| Current Assets | $371.4M+16.5% | $357.5M+24.4% | $358.1M+23.4% | $337.5M+17.2% | $318.8M+11.9% | $287.3M+3.8% | $290.1M+3.4% | $288.0M+7.8% |
| Cash & Equivalents | $77.3M+44.6% | $55.8M+47.9% | $64.9M+21.4% | $73.4M+30.7% | $53.5M-2.8% | $37.7M-26.3% | $53.5M-9.3% | $56.2M+5.0% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $103.4M+19.2% | $98.0M+19.6% | $92.4M+15.9% | $90.5M+7.6% | $86.7M+7.3% | $81.9M+0.3% | $79.8M-2.7% | $84.1M+6.8% |
| Accounts Receivable | $97.9M+7.1% | $91.9M+4.6% | $89.8M+13.0% | $88.1M+16.4% | $91.4M+23.8% | $87.8M+18.2% | $79.5M+10.7% | $75.7M+17.7% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $349.9M+37.8% | $251.7M+2.7% | $254.1M+5.5% | $254.0M+2.1% | $253.8M+4.0% | $245.1M0.0% | $241.0M-2.6% | $248.7M+2.4% |
| Total Liabilities | $626.3M+49.7% | $432.7M-12.9% | $436.6M-14.9% | $419.0M-15.9% | $418.5M-15.4% | $496.9M+1.6% | $512.9M+0.4% | $498.4M-0.9% |
| Current Liabilities | $106.9M+60.4% | $92.7M+78.5% | $101.6M+52.0% | $85.8M-43.8% | $66.7M+31.8% | $51.9M+13.3% | $66.8M+15.5% | $152.8M+178.1% |
| Non-Current Liabilities | $519.4M+47.6% | $340.0M-23.6% | $335.0M-24.9% | $333.1M-3.6% | $351.8M-20.7% | $445.0M+0.4% | $446.1M-1.5% | $345.6M-22.8% |
| Long-Term Debt | $363.4M+68.6% | $215.4M-31.5% | $215.1M-31.5% | $214.9M+0.3% | $215.5M-31.2% | $314.6M+0.5% | $314.2M+2.8% | $214.3M-29.9% |
| Total Equity | $445.6M+6.1% | $450.5M+53.1% | $448.2M+62.3% | $438.7M+44.0% | $419.9M+42.3% | $294.3M-0.2% | $276.2M-2.0% | $304.7M+12.0% |
| Retained Earnings | -$63.6M-5.2% | -$50.1M+18.9% | -$51.5M+15.9% | -$53.9M-20.4% | -$60.4M-42.2% | -$61.8M-53.0% | -$61.3M-27.9% | -$44.8M-1.9% |
AORT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.3M-108.4% | $1.2M+106.8% | $19.6M+92.9% | $22.3M+94.3% | $15.0M+144.7% | -$17.0M-208.6% | $10.1M-6.4% | $11.5M+58.4% |
| Depreciation & Amortization | $6.7M+21.8% | $6.3M+16.4% | $5.8M-8.5% | $5.7M-6.4% | $5.5M-6.0% | $5.4M-7.8% | $6.3M+8.2% | $6.1M+6.1% |
| Stock-Based Compensation | N/A | $8.4M+4.6% | N/A | N/A | N/A | $8.0M+131.3% | N/A | N/A |
| Capital Expenditures | $10.7M+227.0% | $8.0M+120.0% | $27.5M+1830.3% | $4.6M+26.7% | $3.3M+30.8% | $3.6M+0.7% | $1.4M-46.6% | $3.6M+76.0% |
| Free Cash Flow | -$12.0M-202.5% | -$6.8M+66.7% | -$7.9M-191.2% | $17.7M+125.9% | $11.7M+223.7% | -$20.6M-126.2% | $8.7M+6.7% | $7.8M+51.4% |
| Investing Cash Flow | -$129.4M-3837.0% | -$10.5M-188.7% | -$30.5M-167.0% | -$4.6M+56.7% | -$3.3M-30.8% | -$3.6M-0.7% | -$11.4M-328.1% | -$10.6M-414.5% |
| Financing Cash Flow | $152.4M+5765.6% | $463K-88.2% | $2.4M+1296.6% | $2.3M+57.3% | $2.6M+1535.4% | $3.9M+434.2% | $174K+110.7% | $1.5M+262.0% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AORT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0%-0.7pp | 64.8%+0.6pp | 63.1%-0.1pp | 65.6%+1.9pp | 64.7%+0.1pp | 64.2%-0.4pp | 63.2%-2.0pp | 63.7%-0.3pp |
| Operating Margin | -6.7%-14.1pp | 5.0%+2.8pp | 9.2%+6.5pp | 11.1%+6.5pp | 7.4%+0.8pp | 2.2%-23.8pp | 2.7%-0.6pp | 4.6%+6.0pp |
| Net Margin | -10.7%-11.9pp | 1.2%+1.7pp | 2.1%+19.0pp | 5.7%+8.1pp | 1.2%+3.4pp | -0.5%-8.2pp | -16.9%-12.7pp | -2.4%+8.8pp |
| Return on Equity | -3.0%-3.4pp | 0.3%+0.5pp | 0.5%+6.5pp | 1.5%+2.2pp | 0.3%+1.0pp | -0.2%-2.7pp | -6.0%-4.6pp | -0.8%+2.8pp |
| Return on Assets | -1.3%-1.4pp | 0.2%+0.2pp | 0.3%+2.4pp | 0.8%+1.0pp | 0.2%+0.4pp | -0.1%-1.0pp | -2.1%-1.6pp | -0.3%+1.0pp |
| Current Ratio | 3.47-1.3x | 3.86-1.7x | 3.53-0.8x | 3.93+2.0x | 4.78-0.9x | 5.53-0.5x | 4.34-0.5x | 1.88-3.0x |
| Debt-to-Equity | 0.82+0.3x | 0.48-0.6x | 0.48-0.7x | 0.49-0.2x | 0.51-0.5x | 1.070.0x | 1.14+0.1x | 0.70-0.4x |
| Asset Turnover | 0.120.0x | 0.130.0x | 0.130.0x | 0.130.0x | 0.130.0x | 0.130.0x | 0.120.0x | 0.120.0x |
| FCF Margin | -9.6%-19.9pp | -5.9%+14.9pp | -6.9%-15.8pp | 15.6%+7.4pp | 10.4%+6.7pp | -20.8%-11.5pp | 9.0%+0.2pp | 8.2%+2.3pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Artivion, Inc. AORT | FY2025 | $441.3M | $9.8M | 2.2% | $1.1B | 49/100 |
| Enovis Corporation ENOV | FY2025 | $2.2B | -$1.2B | -52.7% | $1.1B | 34/100 |
| CONMED Corporation CNMD | FY2025 | $1.4B | $47.1M | 3.4% | $1.4B | 53/100 |
| UFP Technologies Inc UFPT | FY2025 | $602.8M | $68.3M | 11.3% | $2.3B | 72/100 |
| NovoCure Limited NVCR | FY2025 | $655.4M | -$136.2M | -20.8% | $1.7B | 63/100 |
| Integra LifeSciences Holdings IART | FY2025 | $1.6B | -$516.8M | -31.6% | $1.1B | 37/100 |
Where Artivion, Inc. Ranks
Frequently Asked Questions
What is Artivion, Inc.'s annual revenue?
Artivion, Inc. (AORT) reported $441.3M in total revenue for fiscal year 2025. This represents a 13.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Artivion, Inc.'s revenue growing?
Artivion, Inc. (AORT) revenue grew by 13.6% year-over-year, from $388.5M to $441.3M in fiscal year 2025.
Is Artivion, Inc. profitable?
Yes, Artivion, Inc. (AORT) reported a net income of $9.8M in fiscal year 2025, with a net profit margin of 2.2%.
What is Artivion, Inc.'s EBITDA?
Artivion, Inc. (AORT) had EBITDA of $56.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Artivion, Inc. have?
As of fiscal year 2025, Artivion, Inc. (AORT) had $64.9M in cash and equivalents against $215.1M in long-term debt.
What is Artivion, Inc.'s gross margin?
Artivion, Inc. (AORT) had a gross margin of 64.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Artivion, Inc.'s operating margin?
Artivion, Inc. (AORT) had an operating margin of 7.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Artivion, Inc.'s net profit margin?
Artivion, Inc. (AORT) had a net profit margin of 2.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Artivion, Inc.'s return on equity (ROE)?
Artivion, Inc. (AORT) has a return on equity of 2.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Artivion, Inc.'s free cash flow?
Artivion, Inc. (AORT) generated $839K in free cash flow during fiscal year 2025. This represents a -92.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Artivion, Inc.'s operating cash flow?
Artivion, Inc. (AORT) generated $39.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Artivion, Inc.'s total assets?
Artivion, Inc. (AORT) had $884.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Artivion, Inc.'s capital expenditures?
Artivion, Inc. (AORT) invested $39.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Artivion, Inc. spend on research and development?
Artivion, Inc. (AORT) invested $31.0M in research and development during fiscal year 2025.
What is Artivion, Inc.'s current ratio?
Artivion, Inc. (AORT) had a current ratio of 3.53 as of fiscal year 2025, which is generally considered healthy.
What is Artivion, Inc.'s debt-to-equity ratio?
Artivion, Inc. (AORT) had a debt-to-equity ratio of 0.48 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Artivion, Inc.'s return on assets (ROA)?
Artivion, Inc. (AORT) had a return on assets of 1.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Artivion, Inc.'s P/E ratio?
Artivion, Inc. (AORT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.1B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Artivion, Inc.'s price-to-sales ratio?
Artivion, Inc. (AORT) trades at 2.3x sales, its market capitalization divided by revenue of $471.5M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.1B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Artivion, Inc.'s Altman Z-Score?
Artivion, Inc. (AORT) has an Altman Z-Score of 2.35, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Artivion, Inc.'s Piotroski F-Score?
Artivion, Inc. (AORT) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Artivion, Inc.'s earnings high quality?
Artivion, Inc. (AORT) has an earnings quality ratio of 4.08x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Artivion, Inc. cover its interest payments?
Artivion, Inc. (AORT) has an interest coverage ratio of 1.27x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Artivion, Inc.?
Artivion, Inc. (AORT) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.